We report that protease nexin-1 (PN-1), a serine protease inhibitor known to have neurite-promoting effects, is made by Schwann cells in tissue culture. Three modalities have been used to demonstrate the presence of PN-I in Schwann cell cultures. Immunostaining of the cultures with anti-PN-1 antibody gives positive staining over cells and matrix. Western blots of Schwann cell conditioned medium (CM) using anti-PN-I antibody show a band that co-migrates with the PN-1 standard at 45 kDa. Biochemical assay for protease inhibitory activity shows that CM inhibits thrombin activity in a calorimetric assay. The CM-mediated inhibition of thrombin is reversed if the CM is pre-incubated with anti-PN-I antibody.
It has been hypothesized that the balance between proteolytic and protease inhibitory activity plays an important role in normal neuronal development and in the response of the nervous system to injury [16] . The protease nexins are a group of serine protease inhibitors that were originally described in conditioned media from forskolin fibroblast cultures. They are classified by molecular weight and by the pattern of proteases they inhibit [10] . Protease nexin-1 (PN-I) is the best characterized of the nexins, and has been demonstrated in conditioned media from a variety of cell types [1], including astroglia [18] . PN-1 has been shown to be identical to the glialderived neurite promoting factor (now re-named gliaderived nexin) that affects neuronal migration and neurite extension [5, 11] . Changes in PN-1 activity have been demonstrated in the normal developmental processes of the central nervous system (CNS) [21] and in the pathological processes associated with Alzheimer's disease [19] . In the peripheral nervous system, sciatic nerve injury has been shown to result in increases in PN-1 message RNA [15] . Although tissue culture studies suggest that astrocytes are potentially major producers of PN-1 in the CNS, the cell type responsible for PN-1 production in the peripheral nervous system (PNS) has not previously been clearly identified. Schwann cells share many properties with astrocytes and are candidates for this role. The present report describes the immunocytochemical, biochemical and functional demonstration of PN-1 in cultured Schwann cells. Sciatic nerve Schwann cells were prepared and purified according to the method described by Brockes et al. [3] . Briefly, sciatic nerves were dissected from neonatal Sprague-Dawley rats (Charles River, Wilmington, MA), dissociated with 0.1% collagenase and 0.25 % trypsin in L-5 medium and plated overnight on poly-L-lysine in Dulbecco's modified Eagle's medium (DMEM) containing 10 % fetal calf serum (Gibco, Grand Island, NY) and 10 -5 M cytosine arabinoside. After 48-72 h, the cells were trypsinized and suspended in mouse anti-Thy 1.1 (TIB 103, American Type Culture Collection, Rockville, MD) followed by rabbit complement (Pel-Freeze, Rogers, AR) to lyse the fibroblasts. Following this, Schwann cells were plated in 35 mm tissue culture plates coated with poly-L-lysine and grown in medium containing 2 x 10 6 forskolin and bovine pituitary extract as described by Porter et al. [17] . After one week in culture, immunostaining was done with anti-Thy 1.1 and fluorescein-conjugated goat anti-mouse immunoglobulin (Sigma, St. Louis, MO) to confirm removal of fibroblasts. If positive cells were observed, the complement lysis was repeated. Cells were passaged once they reached confluence and after about three months in culture, they began to show signs of becoming autocrine, as described by Porter et al. [17] for Schwann cells grown under similar conditions. As in that previous study, cells that became mitogen-independent displayed a range of morphologies from broad and flat to typical early passage Schwann cells. The cultures remained Thy 1.1 negative throughout these experiments. To prepare conditioned media the cultures were placed in serum-free medium containing 1 mg/ml BSA for 48h. This was done to prevent complex formation between PN-1 and proteases in the FCS. After removal from the cells the medium was concentrated 5-fold using Centricon filters (Amicon, Danvers, MA) and assayed for thrombin inhibitory activity in a Chromozym-TH (Boehringer Mann° heim, Indianapolis, IN) calorimetric assay [2] . Preincubation of the conditioned medium with anti-PN-1 antibody was used to test whether the thrombin inhibition was due to PN-1. A polyclonal rabbit anti-PN-1 antibody [19] was used in all experiments. For the immunohistochemistry and the Western blotting, a protein A fraction was prepared from the anti-PN I serum using an Affi-Gel Protein A MAPS kit (Biorad, Riverside, CA). PN-1 was purified from C6 glioma conditioned medium by the method of Scott et al. [22] and conjugated to CN Br Sepharose 4B (Pharmacia, Piscataway, N J) according to the manufacturer's instructions. The PN-1-Sepharose was then used to affinity-purify the protein A fraction. The protein A fraction remaining after removal of the Sepharose beads was used as an anti-PN-1 antibodydepleted control. Affinity purified anti-PN-1 reacted positively with purified PN-1 in a Western blot system, while the anti-PN-1 depleted control was negative.
To test for PN-1 activity in Schwann cell conditioned medium, the cells were cultured in serum-free medium without growth factors for 24-48 h. The medium was then harvested and concentrated ten-fold in a Centricon system (Amicon). The concentrated medium was then electrophoresed on a 10% polyacrylamide gel [14] and electroblotted onto nitrocellulose [23] . The nitrocellulose was then cut into strips which were immunostained with the rabbit anti-PN I (or with the anti-PN-l-depleted antiserum) and developed by incubation with alkaline phosphatase conjugated anti-rabbit IgG (Promega, Madison, WI). Immuno-cytochemical testing of the cultures for PN-1 activity was done by standard procedures [4] on cells seeded at 1-2 x 10-5/well on poly-L-lysinecoated glass cover slips in 12 well plates. In initial studies, Schwann cell cultures were immunostained with the anti-PN-I antibody and a rhodamine-conjugated second antibody to assay for the presence of PN-1. Primary cells showed a typical Schwann cell morphology under phase microscopy ( Fig. 1A) and expressed faint traces of positive staining for PN-1 in either the presence or absence of growth factors (Fig.  1B) . In contrast, autocrine Schwann cells showed a flattened morphology (Fig. 1C) and appeared to produce considerable quantities of PN-I [10] . The pattern was suggestive of extracellular matrix staining and appeared strongest in those parts of the dish not occupied by Schwann cells. Some punctate staining of cell membranes was also observed. A similar pattern was seen with affinity purified anti-PN-1. There was no staining above background in either the primary or the autocrine Schwann cells when the PN-1 antibody-depleted prepa- ration was used. Although the autocrine cells are not dependent on exogenous growth factors for proliferation in vitro, some autocrine cells were also cultured with growth factors. This treatment led to a clear reduction of PN-1 immunostaining when compared to cultures maintained without growth factors. Based on the results from the immunocytochemical studies, autocrine cells grown in the absence of growth factors were selected as the best source of the immunoreactive PN-l-like material and were therefore used to condition medium for biochemical and functional assays for PN-1. Conditioned medium was electrophoresed on SDS-PAGE, electroblotted to nitrocellulose and immunostained with anti-PN-1 antibody (Fig. 2) . The immunostaining revealed a protein from the conditioned medium that migrated close to the position of the purified PN-1 standard. Immunostaining with control antibody preparations was negative.
To assay for the presence of PN-l-like protease inhibitory activity the conditioned medium was tested in a Chromozym-TH assay. Pre-incubation of thrombin with the conditioned medium led to a 23% inhibition of thrombin activity in the assay as shown in the graph from a typical experiment (Fig. 3) . This inhibition was prevented by preincubation of the conditioned medium with anti-PN-1 antibody.
This report presents immunohistochemical, biochemi- cal and functional data that support the premise that cultured autocrine Schwann cells produce PN-1 or a very closely related molecule. Schwann cell cultures had positive immunostaining for PN-1. Western blots of conditioned medium showed a band that co-migrated with a PN-1 standard. A functional assay for thrombin inhibition showed inhibition that could itself be inhibited by anti-PN-1 antibody. PN-1 is the best studied of the nexin family of serine protease inhibitors and has been shown to be identical to the glial-derived neurite promoting factor [5, 11] . Although PN-1 production has been demonstrated in astrocytes [18] , it has not previously been reported in Schwann cells. Schwann cells interact with neurons both during normal development and in response to nerve injury. Presumably, neuron-glia signalling modulates both glial mitogenesis and glial production of neurite promoting/trophic factors. Although Howard has reported that in fibroblast cultures PN-1 secretion is constitutive [8] , PN-1 secretion has not been fully characterized either in astrocytes or in Schwann cells. Growth in culture, in the absence of neurons (or the target cells for fibroblast PN I), probably represents an abnormal system lacking in controls and resulting in constitutive production. It is of note that PN-1 production in the Schwann cells appeared to be greatest in the autocrine cells. Porter et al. have described these cells as retaining cell surface markers and the ability to ensheathe axons, but also having the ability to proliferate in the absence of growth factors or mitogens [17] . It has been suggested that they have lost the ability to regulate their own response to the autocrine factor that they secrete. These cells also make more autocrine factor than do primary Schwann cells. The high levels of PN-I production in these cells may be analogous to their high levels of autocrine factor production. The suppression of autocrine cell production of PN-I by addition of growth factors may represent restoration of a modulating signal.
In fibroblast culture PN-1 is secreted and much of it becomes bound to the extracellular matrix [4] . Schwann cells also produce extracellular matrix and the staining pattern seen in the Schwann cell cultures suggests that a similar process is going on in these cultures. It is reported that matrix binding in fibroblast cultures changes the affinity of PN-1 for substrate proteases [25] .
Although the exact mechanism(s) through which PN-1 exerts its effects on neurons has yet to be definitively demonstrated, it is of note that the enzymes inhibited by PN-1 are important in neuronal migration [24] , neurite extension [6, 13] , nerve muscle synapse formation and response to injury [7] , neuron ensheathment by Schwann cells [9] and modification of the neurotrophic factor flnerve growth factor [12, 20] . As Schwann cells are 45 involved in many of these processes, it is perhaps not surprising to find that Schwann cells make PN-1. There is a growing body of knowledge on neuronal and glial proteolytic activity in both the central and peripheral nervous systems [26] . It has been suggested that a crucial balance between proteolytic and protease inhibitory activity is a sine qua non for both normal neuronal development and for neuronal response to injury. Further studies are needed to elucidate the role of Schwann cell PN-1 both in normal development and in the response to nerve injury.
